Marksans Pharma, an Indian pharmaceutical company, completed the acquisition of manufacture and supply of bulk pharmaceutical formulations business of Tevapharm India, a pharmaceutical company. Financial terms were not disclosed. "I am excited to share that the acquisition has potential to significantly expand our manufacturing capability and accelerate our core growth strategy. It will supplement our innovative product portfolio, as we plan to begin manufacturing of creams, ointments, etc. in India. It is also a testament to our commitment to invest in product innovation, expand capacities, and drive market share gains. We are confident that this acquisition will lead to transformational growth journey unlocking further value for our shareholders," Mark Saldana, Marksans Pharma Promoter and Managing Director.